Inhibrx Biosciences INBX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 79.00 | 104.30 | -2.11 | -30,923 | -33 | |
| 2025Q3 | 33.68 | 105.42 | -2.28 | -33,812 | -35 | |
| 2025Q2 | 14.27 | 107.36 | 0.12 | -1.85 | -27,389 | -29 |
| 2025Q1 | 13.99 | 105.61 | 0.12 | -2.80 | -42,901 | -43 |
| 2024Q4 | 15.40 | 104.31 | 0.13 | -4.47 | -49,928 | -48 |
| 2024Q3 | 15.66 | 106.69 | 0.14 | -5.66 | -46,797 | -44 |
| 2024Q2 | 14.17 | 125.48 | -160,898 | 1,858 | ||
| 2024Q1 | 104.60 | -1.44 | -73,825 | -79 | ||
| 2023Q4 | 105.42 | -1.82 | -88,289 | -94 | ||
| 2023Q3 | 105.02 | -1.10 | -45,827 | -52 | ||
| 2023Q2 | 105.61 | -1.08 | -41,339 | -47 | ||
| 2023Q1 | 99.84 | -1.12 | -43,766 | -49 | ||
| 2022Q4 | 98.95 | -0.95 | -35,500 | -41 | ||
| 2022Q3 | 99.73 | -0.90 | -30,003 | -35 | ||
| 2022Q2 | 100.05 | -0.97 | -34,597 | -38 | ||
| 2022Q1 | 100.13 | -0.80 | -29,017 | -31 | ||
| 2021Q4 | 99.97 | -0.55 | -19,404 | -21 | ||
| 2021Q3 | 99.99 | -0.54 | -18,801 | -21 | ||
| 2021Q2 | 100.03 | -0.55 | -19,801 | -21 | ||
| 2021Q1 | 100.09 | -0.51 | -18,558 | -19 |